KC-3393

K562-CD20-High-GFP-Luc2 Cell Line

×
26983
Home » K562-CD20-High-GFP-Luc2 Cell Line

Background of K562-CD20-High-GFP-Luc2 Cell Line

MS4A1 encodes membrane spanning 4-domains A1 and is also known as B1. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein.

Specifications

Catalog NumberKC-3393
Cell Line NameK562-CD20-High-GFP-Luc2 Cell Line
NCBI/UniProt Accession NumberNM_021950.4
Clone Number3-4#
Host Cell LineK562-Luc2
DescriptionK562-CD20-High-GFP-Luc2 is a stable engineered cell line expressing human CD20-High-GFP-Luc2
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10%FBS+1μg/mL Puromycin
Selection MarkerPuromycin
MorphologyLymphoblast
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 19–36 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

K562-CD20-High-GFP-Luc2 cell line was generated using a lentiviral vector expressing the human CD20-High-GFP-Luc2 sequence.

Characterization

Figure 1: Characterization of CD20 overexpression in K562-CD20-High-GFP-Luc2 stable clone using FACS.

Figure 2: Characterization of endogenous CD20 expression in K562-Luc2 cells using cells FACS.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Fattah MA, Habib MA Aflatoxin M(1) in Milk and Aflatoxin B(1) in Animal Feed in Bangladesh: A Systematic Review, Meta-Analysis and Literature-Based Dietary Risk Assessment. Veterinary medicine and science. 2026 Nov;12(6):e71284. PMID: 42886739. doi: 10.1002/vms3.71284.
  2. Sleilaty C, Hnein M, Lattouf T et al. Aflatoxin B1, Gut Microbiota Dysbiosis, and the Intestinal Barrier: Implications for the Gut-Liver Axis and Extrahepatic Cancer Risk. Toxins. 2026 Aug 24;18(9):. PMID: 42784285. doi: 10.3390/toxins18090361.
  3. Shi H, Mu J, Li R et al. Flavonoids as multi-target protective agents against aflatoxin B1 toxicity: mechanistic convergence and translational challenges. Poultry science. 2026 Sep 13;105(12):107774. PMID: 42767185. doi: 10.1016/j.psj.2026.107774.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.